T. Moreau

Mechanism of first-dose cytokine-release syndrome by CAMPATH 1-H: involvement of CD16 (FcgammaRIII) and CD11a/CD18 (LFA-1) on NK cells.

Mark Wing, T. Moreau, Judith Greenwood et al. · Journal of Clinical Investigation · 1996 · 254 citations · Full text

First-dose Cytokine-release Syndrome, Immunology, Immune Regulation +17

Preliminary evidence from magnetic resonance imaging for reduction in disease activity after lymphocyte depletion in multiple sclerosis

T. Moreau, Neil Scolding, Alastair Compston et al. · The Lancet · 1994 · 187 citations

Autoimmune Disease, Disease Progression, Neurological Disorder +11

Clinica: An Open-Source Software Platform for Reproducible Clinical Neuroscience Studies

Alexandre Routier, Ninon Burgos, Mauricio Díaz et al. · Frontiers in Neuroinformatics · 2021 · 124 citations · Full text

Incidence Trends of Ischemic Stroke and Transient Ischemic Attacks in a Well-Defined French Population From 1985 Through 1994

M. Lemesle, C Milan, Jean Faivre et al. · Stroke · 1999 · 92 citations · Full text

Increase in multiple sclerosis relapse rate following in vitro fertilization

David Laplaud, Emmanuelle Leray, P. Barrière et al. · Neurology · 2006 · 66 citations

Reproductive Sciences, Fertility, Neurological Disorder +19